PD Dr. Benjamin Frey

Medizinische Fakultät Department of Radiation Oncology

Low-dose Radiotherapy for painful Finger Joint Arthrosis (2020) Weissmann T, Ott O, Putz F, Becker I, Fietkau R, Donaubauer AJ, Frey B Conference contribution The influence of radiation on bone and bone cells—differential effects on osteoclasts and osteoblasts (2020) Donaubauer AJ, Becker I, Fietkau R, Frey B, Gaipl U, Deloch L Journal article, Review article Priming of Anti-tumor Immune Mechanisms by Radiotherapy Is Augmented by Inhibition of Heat Shock Protein 90 (2020) Ernst A, Hennel R, Krombach J, Kapfhammer H, Brix N, Zuchtriegel G, Uhl B, et al. Journal article Low dose radiation therapy, particularly with 0.5 gy, improves pain in degenerative joint disease of the fingers: Results of a retrospective analysis (2020) Donaubauer AJ, Zhou J, Ott OJ, Putz F, Fietkau R, Keilholz L, Gaipl U, et al. Journal article Early Mortality of Brain Cancer Patients and its Connection to Cytomegalovirus Reactivation During Radiochemotherapy (2020) Goerig N, Frey B, Korn K, Fleckenstein B, Überla K, Schmidt M, Dörfler A, et al. Journal article Differences of the immune phenotype of breast cancer cells after ex vivo hyperthermia by warm-water or microwave radiation in a closed-loop system alone or in combination with radiotherapy (2020) Hader M, Savcigil DP, Rosin A, Ponfick P, Gekle S, Wadepohl M, Bekeschus S, et al. Journal article Graphene Oxide Nanosheets for Localized Hyperthermia-Physicochemical Characterization, Biocompatibility, and Induction of Tumor Cell Death (2020) Podolska M, Barras A, Alexiou C, Frey B, Gaipl U, Boukherroub R, Szunerits S, et al. Journal article Dose reduction to the swallowing apparatus and the salivary glands by de-intensification of postoperative radiotherapy in patients with head and neck cancer: First (treatment planning) results of the prospective multicenter DIREKHT trial (2020) Haderlein M, Speer S, Ott O, Lettmaier S, Hecht M, Semrau S, Frey B, et al. Journal article Combination of gas plasma and radiotherapy has immunostimulatory potential and additive toxicity in murine melanoma cells in vitro (2020) Pasqual-Melo G, Sagwal SK, Freund E, Gandhirajan RK, Frey B, von Woedtke T, Gaipl U, Bekeschus S Journal article Olanzapine combined with 5-hydroxytryptamine type 3 receptor antagonist (5-HT3 RA) plus dexamethasone for prevention and treatment of chemotherapy-induced nausea and vomiting in high and moderate emetogenic chemotherapy: a systematic review and meta-analysis of randomised controlled trials (2020) Zhou JG, Huang L, Jin SH, Xu C, Frey B, Ma H, Gaipl U Journal article, Review article